We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
15 November News.
- Abstract
The article offers medical research news briefs as of November 15, 2014. The U.S. Food and Drug Administration (FDA) drug approval for oritavancin, a single-dose intravenous drug for treating acute bacterial skin infections. Medical agendas of the World Alliance Against Antibiotic Resistance (WAAAR), a nonprofit organization on antibiotic resistance awareness programs. San Diego-based drug maker Mapp Biopharmaceutical Inc. collaborates with drugstores for production of Ebola virus antibodies.
- Subjects
MEDICAL research; COMMUNICABLE diseases; DRUG development; DRUG approval; DRUG resistance; UNITED States. Food &; Drug Administration; PREVENTION
- Publication
Clinical Infectious Diseases, 2014, Vol 59, Issue 10, pi
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciu745